ALPMF Stock Latest News
Company AnnouncementsAstellas Tests Hot-Flash Drug in India, Opening a Potential New Market1w agoALPMF
Pre-EarningsIs ALPMF a Buy, Before Earnings?3M ago
Company AnnouncementsAstellas Halts Early KRAS G12D Cancer Trial: What It Means for ALPMF Investors4M agoALPMF
Company AnnouncementsAstellas Wraps Up Real-World Safety Study on Smyraf, Clarifying RA Market Outlook5M agoALPMF
Company AnnouncementsPfizer and Astellas Advance New Bladder Cancer Combo in Early Clinical Trial5M agoPFECompany AnnouncementsAstellas Launches Five-Year CSP2026 Plan Targeting Pipeline-Led Record Revenues5M ago
Company AnnouncementsAstellas Extends Global Performance-Linked Stock Incentives for Executives6M ago
Company AnnouncementsAstellas Extends Performance-Linked Stock Incentive Plan for Directors in FY20266M ago
Company AnnouncementsAstellas Books Major Impairment and Extraordinary Losses in FY2025 Non-Consolidated Results6M ago
Company AnnouncementsAstellas Pharma Announces New Board Slate and Governance Changes for 20266M agoCompany AnnouncementsAstellas’ Menopause Drug Fezolinetant Hits Key Safety Milestone in Japan7M agoALPMF
Company AnnouncementsAstellas Highlights R&D Strategy While Flagging Market and Development Risks7M ago
Company AnnouncementsAstellas and HOVON Phase 3 AML Trial for Xospata Misses Survival Goal8M ago
Company AnnouncementsAstellas Flags Risks and Uncertainties Around Sustainability Plans and Pipeline8M ago
Market NewsWhy Is Vir Biotechnology Stock Up Today?8M agoVIR
Company AnnouncementsAstellas Settles Myrbetriq Patent Disputes with Lupin and Zydus9M ago



